Clinical and Immunologic Responses of HLA-A3 + Breast Cancer Patients Vaccinated with the HER2/ neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial

Autor: Patil, Ritesh, Clifton, Guy T., Holmes, Jarrod P., Amin, Asna, Carmichael, Mark G., Gates, Jeremy D., Benavides, Linda H., Hueman, Matthew T., Ponniah, Sathibalan, Peoples, George E.
Zdroj: In Journal of the American College of Surgeons 2010 210(2):140-147
Databáze: ScienceDirect